UPDATE 1-Otsuka loses lawsuit challenging FDA approval of generic Abilify

May 28 (Reuters) – Otsuka Pharmaceutical Co Ltd has lost a lawsuit challenging the U.S. Food and Drug Administration’s decision to allow generic versions of the company’s antipsychotic drug Abilify.





Source: Technology Sector News

Leave a Reply

Your email address will not be published. Required fields are marked *

18 − thirteen =